Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Mathematics, theoretical physics, computational sciences and cancer

Share :
Published: 7 Apr 2009
Views: 11672
Rating:
Save
Dr Alberto D'Onofrio - Group Leader in Theoretical Biology and Medicine, Department of Experimental Oncology, European Institute of Oncology, Milan

Dr Alberto D'Onofrio, Group Leader in Theoretical Biology and Medicine, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy, discusses the part mathematics, theoretical physics and computer sciences play in studying cancer.

Related Videos

Urinary markers in the surveillance setting of non-muscle invasive bladder...
Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark
Urinary markers in the surveillance setting of non-muscle invasive bladder cancer ( Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark )
10 Apr 2024
Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective...
Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy
Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC ( Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy )
10 Apr 2024
EAU 2024: Bladder cancer latest
Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea...
EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )
9 Apr 2024
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )
26 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024
Pembrolizumab a promising option for MIUC patients after radical surgery
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pembrolizumab a promising option for MIUC patients after radical surgery ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
5 Feb 2024
ASCO GU 2024: Current best practice for mRCC
Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu
ASCO GU 2024: Current best practice for mRCC ( Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu )
1 Feb 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation